From GlobeNewswire:

Myriad Genetics will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2024 at 4:30pm PST/ 7:30pm EST. The presentation will be live on Myriad’s website and will also be available later in an archived edition.

Myriad Genetics is a genetic testing and precision medicine company that aims to improve health and well-being by developing and offering genetic tests that assess the risk of disease and guide treatment decisions. For more information, visit www.myriad.com.

Investor Contact:
Matt Scalo
(801) 584-3532
[email protected]

Media Contact:
Glenn Farrell
(385) 318-3718
[email protected]



Read more: Myriad Genetics to Present at 42nd Annual J.P. Morgan